APA (7th ed.) Citation

E, E., A, C., L, M., C, C., M, T., E, P., . . . J, F. (2026). MicroLC-HRMS selective quantification of a biotherapeutic fusion protein in plasma and cerebrospinal fluid of patients with Lafora disease using a linker-containing signature peptide. Journal of pharmaceutical and biomedical analysis, 279, 117574. https://doi.org/10.1016/j.jpba.2026.117574

Chicago Style (17th ed.) Citation

E, Esposito, et al. "MicroLC-HRMS Selective Quantification of a Biotherapeutic Fusion Protein in Plasma and Cerebrospinal Fluid of Patients with Lafora Disease Using a Linker-containing Signature Peptide." Journal of Pharmaceutical and Biomedical Analysis 279 (2026): 117574. https://doi.org/10.1016/j.jpba.2026.117574.

MLA (9th ed.) Citation

E, Esposito, et al. "MicroLC-HRMS Selective Quantification of a Biotherapeutic Fusion Protein in Plasma and Cerebrospinal Fluid of Patients with Lafora Disease Using a Linker-containing Signature Peptide." Journal of Pharmaceutical and Biomedical Analysis, vol. 279, 2026, p. 117574, https://doi.org/10.1016/j.jpba.2026.117574.